Peptide Initiative

Peptide profile · Hormone Support

Gonadorelin (GnRH)

The master hormone that controls your reproductive system and fertility

Moderate human trialsPreviously FDA approved: FACTREL (1982)…
2-4 minutesHalf-life
Varies by route: ~5-20%Bioavailability (intranasal), 100% (IV/IM injections)
1182.3Molecular weight

Molecular formula

C55H75N17O13

CAS number
34973-08-5
PubChem
638793
Developed · 1971
Andrew V. Schally and Roger Guillemin, Isolated and sequenced 1971; marketed as Factrel by Wyeth

Amino acid sequence

pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2

Reproductive HealthGonadorelin directly controls your body's fertility hormones, making it one of the most fundamental tools for supporting natural reproduction and addressing fertility challenges.

9.5

Hormone BalanceBy triggering the release of LH and FSH, gonadorelin helps restore natural hormonal rhythms and balance in your reproductive system.

9.0

Ovulation SupportGonadorelin works to promote healthy ovulation timing and quality, which is essential for conception and reproductive success.

8.8

Ratings out of 10.

100mcg

Every documented dose level

PhaseDoseFrequencyRoute
One-time diagnostic test100 mcgSingle doseSubcutaneous
One or more ovulatory cycles; reassessed at 21-day intervals5 mcg per pulse (range 1-20 mcg)Every 90 minutes via pulsatile pumpIntravenous
Build my protocolBuild my protocol opens your schedule and dose log to save, share and keep on your phone.

Best for improving fertility and conception chances & regulating irregular menstrual cycles

Best for

  • Improving fertility and conception chances

    Gonadorelin (GnRH) is particularly well-suited for individuals focused on improving fertility and conception chances. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

  • Regulating irregular menstrual cycles

    Gonadorelin (GnRH) is particularly well-suited for individuals focused on regulating irregular menstrual cycles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

  • Enhancing reproductive hormone levels

    Gonadorelin (GnRH) is particularly well-suited for individuals focused on enhancing reproductive hormone levels. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

  • Supporting natural pregnancy attempts

    Gonadorelin (GnRH) is particularly well-suited for individuals focused on supporting natural pregnancy attempts. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Consider alternatives if

Alternative approaches for hormone support supportConsult your healthcare provider for alternatives to Gonadorelin (GnRH) based on your specific needs and medical history
Alternative hormone-supporting peptidesKisspeptin-10GonadorelinPT-141 (Bremelanotide)
Non-peptide hormone supportClomiphene citrateAnastrozoleLifestyle modifications (sleep, exercise)

Do not use if

  • Pregnancy or breastfeeding
  • Hormone-sensitive cancers (breast, prostate, ovarian)
  • Severe pituitary or hypothalamic disease
  • Undiagnosed abnormal vaginal bleeding
  • Known hypersensitivity to GnRH

Use with caution if

  • You are taking other medications—discuss potential interactions with your healthcare provider
  • You have a history of liver or kidney disease
  • You are elderly or have multiple medical conditions
  • You are planning surgery in the near future—inform your surgeon about Gonadorelin (GnRH) use
  • You have any chronic health conditions that require regular monitoring

Not sure?

Compare Gonadorelin (GnRH) with similar peptides to find the best fit for your goals.

Route

Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training

Best sites

  • Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection
  • Front of thighs—middle to upper portion of the outer leg
  • Back of upper arm—outer area (may need assistance from another person)

The Gonadorelin (GnRH) injection guide covers reconstitution · step-by-step technique · storage · a sample daily schedule.

15 common side effects · 2 serious

Emergency signs first, then what this page and MedlinePlus say.

Gonadorelin is native GnRH and carries the safety profile established over 40+ years of clinical use in reproductive endocrinology.

As the body's natural hormone, it produces minimal local side effects when dosed appropriately.

The critical safety concern with gonadorelin is the initial flare effect within 24-48 hours of first dose—temporary elevation in FSH and LH—which can paradoxically suppress sex hormones before the desired stimulation occurs.

This flare makes gonadorelin unsuitable for some conditions and explains why synthetic analogs (agonists, antagonists) are preferred in many modern fertility protocols.

Gonadorelin safety is supported by decades of clinical endocrinology practice and FDA approval as a pituitary-function test (FACTREL, 1982; now discontinued).

Studies published in Fertility and Sterility and Human Reproduction show appropriate dosing produces predictable hormone responses without hepatotoxicity, nephrotoxicity, or significant cardiovascular effects.

The flare phenomenon is well-characterized physiologically—not an adverse event but an expected pharmacodynamic response requiring timing consideration.


Common side effects · experienced by some users

Mild headache

Mild headache

Management
Consult your healthcare provider for guidance.

Local injection site reactions (redness, swelling)

Local injection site reactions (redness, swelling)

Management
Consult your healthcare provider for guidance.

Temporary hot flashes

Temporary hot flashes

Management
Consult your healthcare provider for guidance.

Mood changes or emotional sensitivity

Mood changes or emotional sensitivity

Management
Consult your healthcare provider for guidance.

Nausea or mild stomach upset

Nausea or mild stomach upset

Management
Consult your healthcare provider for guidance.

Allergic skin reactions

Allergic skin reactions

Management
Consult your healthcare provider for guidance.

Dizziness or lightheadedness

Dizziness or lightheadedness

Management
Consult your healthcare provider for guidance.

Temporary changes in vision

Temporary changes in vision

Management
Consult your healthcare provider for guidance.

Joint or muscle aches

Joint or muscle aches

Management
Consult your healthcare provider for guidance.

Insomnia or sleep disturbances

Insomnia or sleep disturbances

Management
Consult your healthcare provider for guidance.

Severe allergic reactions (difficulty breathing, swelling)

Severe allergic reactions (difficulty breathing, swelling)

Management
Consult your healthcare provider for guidance.

Severe hormonal imbalance symptoms

Severe hormonal imbalance symptoms

Management
Consult your healthcare provider for guidance.

Ovarian hyperstimulation syndrome (OHSS)

Ovarian hyperstimulation syndrome (OHSS)

Management
Consult your healthcare provider for guidance.

Signs of blood clots (chest pain, leg swelling)

Signs of blood clots (chest pain, leg swelling)

Management
Consult your healthcare provider for guidance.

Severe mood changes or depression

Severe mood changes or depression

Management
Consult your healthcare provider for guidance.

Serious side effects

Severe allergic reaction

In rare cases, Gonadorelin (GnRH) may trigger a severe allergic reaction including difficulty breathing, facial swelling, or widespread rash. This requires immediate medical attention.

Management
STOP treatment immediately and seek emergency medical care. Do not restart without medical clearance. Report all allergic reactions to your healthcare provider.


Stop and seek help if

  • Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • Your healthcare provider recommends discontinuation based on your clinical response
  • Development of any new medical condition that may be contraindicated with Gonadorelin (GnRH)
  • Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • Abnormal lab results or clinical markers that suggest adverse effects

Gonadorelin (GnRH) should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.


With other peptides

  • SafehCG (Human Chorionic Gonadotropin) — Complements GnRH action to stimulate final egg maturation and trigger ovulation
  • SafeFSH (Follicle-Stimulating Hormone) — Works synergistically with GnRH to promote follicle development and egg production
  • SafeLH (Luteinizing Hormone) — GnRH directly stimulates LH release, making them natural partners in reproductive function

With medications

  • CautionGnRH Antagonists — These directly block GnRH action, making them counterproductive when used together
  • CautionDopamine Agonists — Can suppress GnRH release and interfere with its reproductive effects
  • CautionLong-acting GnRH Agonists — Initial flare can interfere with gonadorelin's pulsatile signaling mechanism

With supplements

  • SafeMultivitamins — Generally safe to take alongside Gonadorelin (GnRH). Space doses apart if taking oral formulations to ensure optimal absorption.
  • SafeElectrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Moderate human trials · first signs minutes (15-30)

Evidence level

Moderate human trials

(Phase 1-2)

80/100

Regulatory status

Previously FDA approved: FACTREL (1982) as a diagnostic test of pituitary gonadotropin reserve and LUTREPULSE (1989) for ovulation induction

Both human products are discontinued in the US.

Onset of effects

Moderate

(1-2 weeks)


How it works

Gonadorelin is the natural brain hormone (GnRH) that controls sex hormone production.

When given as a medication, it directly stimulates the pituitary to release fertility-related hormones, useful for treating hormone deficiencies.

The deeper mechanism

Gonadorelin is the native 10-amino acid GnRH peptide that binds pituitary GnRH receptors, stimulating gonadotropin synthesis and secretion.


What to expect

  1. Minutes (15-30)

    What you might notice

    • Your pituitary gland receives the signal and begins preparing to release LH and FSH
    • Initial hormone cascades begin

    What's normal

    • Initial response to Gonadorelin (GnRH) is beginning at the cellular level
    • Different individuals experience Gonadorelin (GnRH)'s onset at different rates
    • Transient systemic effects from initial Gonadorelin (GnRH) exposure are common

    What's next

    • Maintain consistent Gonadorelin (GnRH) administration as prescribed
    • Document subjective effects and physical markers daily
    • Schedule a check-in with your provider about initial observations
  2. Hours (1-4)

    What you might notice

    • Peak LH and FSH levels are detected in your bloodstream
    • Your reproductive system is most active during this window

    What's normal

    • Gonadorelin (GnRH) is achieving sufficient receptor engagement
    • Initial mechanism of Gonadorelin (GnRH) is taking effect
    • Early transient effects from Gonadorelin (GnRH) administration are resolving

    What's next

    • Maintain consistent Gonadorelin (GnRH) administration as prescribed
    • Document subjective effects and physical markers daily
    • Schedule a check-in with your provider about initial observations
  3. Days (3-7)

    What you might notice

    • In women, follicles in the ovaries grow in response to the hormones
    • In men, sperm production increases
    • Effects compound with repeated doses

    What's normal

    • Gonadorelin (GnRH) is achieving sufficient receptor engagement
    • Initial mechanism of Gonadorelin (GnRH) is taking effect
    • Early transient effects from Gonadorelin (GnRH) administration are resolving

    What's next

    • Maintain consistent Gonadorelin (GnRH) administration as prescribed
    • Document subjective effects and physical markers daily
    • Schedule a check-in with your provider about initial observations
  4. Weeks (1-3)

    What you might notice

    • Visible changes in ovulation patterns or menstrual cycle regulation
    • Sperm parameters may improve in men
    • Reproductive hormones stabilize

    What's normal

    • Full therapeutic effects of Gonadorelin (GnRH) are well-characterized at this point
    • Maintenance of Gonadorelin (GnRH)'s therapeutic effects is typical
    • Tolerance patterns with Gonadorelin (GnRH) are generally stable over months

    What's next

    • Comprehensive assessment of Gonadorelin (GnRH) efficacy should be conducted
    • Discuss long-term continuation, cycling, or protocol modifications
    • Continue regular monitoring of relevant biomarkers or symptoms

Signs it's working

Treatment Response

  • Improvement in the primary symptoms or condition being treated
  • Positive changes in relevant lab values or clinical markers
  • Consistent, stable response to Gonadorelin (GnRH) over time
  • Reduction in symptom frequency or severity

Signs it's working

General Well-being

  • Improved energy levels and daily functioning
  • Better quality of life related to the treated condition
  • Manageable or absent side effects indicating good tolerance
  • Positive feedback from healthcare provider during check-ups

Not seeing results?

Common reasons

  • Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
  • Insufficient time at target dose—most compounds need several weeks to show full benefits
  • Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
  • Individual variation in response—genetics, metabolism, and other factors affect outcomes
  • Underlying conditions or medications interfering with absorption or effectiveness
  • Improper storage leading to degraded product—always verify proper storage conditions

366 registered studies, 56 still enrolling.

366registered studies
56recruiting now
130phase 3 or 4
95with published results

By phase

Phase 2

81

Phase 3

69

Phase 4

47

Phase 1

22

Phase 2/3

14

Phase 1/2

10

Early Phase 1

5

No phase

118

A trial spanning two phases is counted in both, so these can sum above the total. Observational studies carry no phase.

What kind of research

Gave the drug

333

Records only

33

About 84,946 people took part in the studies that actually administered Gonadorelin (GnRH). Observational studies analyse the records of people already taking it — nobody was given anything for the study, so they are counted separately and cannot show cause and effect.


Most recent

  • NCT07466498 Phase 2Not Yet Recruiting60 enrolled

    Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial

    University of Washington

  • NCT07596212 Phase 1/2Not Yet Recruiting100 enrolled

    BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

    University of Illinois at Chicago

  • NCT07698561 Not Yet Recruiting35 enrolled

    Linzagolix in Adenomyosis and Recurrent Implantation Failure

    Vida Fertility Institute

See all 366 trials for Gonadorelin (GnRH)

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered twice is counted once. A study is counted when Gonadorelin (GnRH) is named as an intervention; studies that only mention it in passing are not.

Is gonadorelin the same as the hormone my brain naturally makes?

Yes! Gonadorelin is identical to the GnRH your hypothalamus produces naturally. It's not a synthetic copy—it's the real hormone used as medicine. Your doctor gives you extra doses to help regulate your reproductive system.

How is gonadorelin different from other fertility drugs?

Gonadorelin works upstream—it tells your pituitary gland to make more LH and FSH. Other fertility drugs (like hCG or FSH) directly provide those hormones. Gonadorelin helps your body make its own, which is closer to natural fertility support.

Can I take gonadorelin if I'm not trying to get pregnant?

Generally no. Gonadorelin is specifically designed to support reproductive function. If you have irregular periods or hormone imbalances unrelated to fertility, your doctor might use it, but it's primarily a fertility medication.

How long do I need to use gonadorelin?

It depends on your situation. Some people use it for just a few days or weeks to time ovulation. Others use it longer to support hormone production. Your fertility specialist will create a treatment plan just for you.

Does gonadorelin have any permanent effects on my body?

No. Once you stop taking gonadorelin, your body returns to its normal hormone patterns. It's a temporary support tool, not a permanent change. Your pituitary gland continues to work normally after you finish treatment.

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for Gonadorelin (GnRH), on one page.

Gonadorelin (GnRH) dosing protocol

Medical disclaimer

Gonadorelin (GnRH) is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Oct 12, 2026